Estimating Australian hospitalisation ratios and costs for wildtype SARS-CoV-2 in 2020
Description
Utilising a retrospective cohort study of SARS-CoV-2 wildtype (Wuhan) strain, we aimed to 1) utilise the unique Australian experience of temporarily eliminating SARS-CoV-2 to document and estimate the hospitalisation demand; and 2) estimate the
